Advertisement
Screener

Cognition Therapeutics, Inc. (CGTX) Dividends, Common Stock

2.8 / 5 stars · 68/120 Roast Me

Cognition Therapeutics, Inc. Dividends, Common Stock

Cognition Therapeutics, Inc. (CGTX) reported Dividends, Common Stock of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Shareholders' Equity

us-gaap:DividendsCommonStock · last filed 2026-08-07

  • Cognition Therapeutics, Inc. dividends, common stock for the quarter ending 2026-06-30 was $0.00.
  • Cognition Therapeutics, Inc. dividends, common stock for the quarter ending 2026-03-31 was $0.00.
  • Cognition Therapeutics, Inc. dividends, common stock for the quarter ending 2025-12-31 was $0.00.
  • Cognition Therapeutics, Inc. dividends, common stock for the quarter ending 2025-09-30 was $0.00.
  • Cognition Therapeutics, Inc. dividends, common stock for fiscal 2025 was $0.00.
  • Cognition Therapeutics, Inc. dividends, common stock for fiscal 2024 was $0.00.
  • Cognition Therapeutics, Inc. dividends, common stock for fiscal 2023 was $0.00.
  • Cognition Therapeutics, Inc. dividends, common stock for fiscal 2022 was $0.00.
Period endDividends, Common Stock 3 monthDividends, Common Stock 6 monthDividends, Common Stock 9 monthDividends, Common Stock 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$0.00
10-Q · filed 2026-08-07
$0.00
derived: sum of 3 quarters · filed 2026-08-07
$0.00
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$0.00
10-Q · filed 2026-05-08
$0.00
derived: sum of 2 quarters · filed 2026-05-08
$0.00
derived: sum of 3 quarters · filed 2026-05-08
$0.00
derived: sum of 4 quarters · filed 2026-05-08
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$0.00
derived: sum of 2 quarters · filed 2026-03-26
$0.00
derived: sum of 3 quarters · filed 2026-03-26
$0.00
10-K · filed 2026-03-26
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2025-11-06
$0.00
10-Q · filed 2025-11-06
$0.00
derived: sum of 4 quarters · filed 2025-11-06
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
$0.00
derived: sum of 3 quarters · filed 2025-08-07
$0.00
derived: sum of 4 quarters · filed 2025-08-07
2025-03-31$0.00
10-Q · filed 2025-05-07
$0.00
derived: sum of 2 quarters · filed 2025-05-07
$0.00
derived: sum of 3 quarters · filed 2025-05-07
$0.00
derived: sum of 4 quarters · filed 2025-05-07
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
$0.00
derived: sum of 2 quarters · filed 2025-03-20
$0.00
derived: sum of 3 quarters · filed 2025-03-20
$0.00
10-K · filed 2025-03-20
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$0.00
derived: sum of 2 quarters · filed 2024-11-13
$0.00
10-Q · filed 2024-11-13
$0.00
derived: sum of 4 quarters · filed 2024-11-13
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$0.00
10-Q · filed 2024-08-08
$0.00
derived: sum of 3 quarters · filed 2024-08-08
$0.00
derived: sum of 4 quarters · filed 2024-08-08
2024-03-31$0.00
10-Q · filed 2024-05-07
$0.00
derived: sum of 2 quarters · filed 2024-05-07
$0.00
derived: sum of 3 quarters · filed 2024-05-07
$0.00
derived: sum of 4 quarters · filed 2024-05-07
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26
$0.00
derived: sum of 2 quarters · filed 2024-03-26
$0.00
derived: sum of 3 quarters · filed 2024-03-26
$0.00
10-K · filed 2024-03-26
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$0.00
derived: sum of 2 quarters · filed 2023-11-02
$0.00
10-Q · filed 2023-11-02
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$0.00
10-Q · filed 2023-08-08
2023-03-31$0.00
10-Q · filed 2023-05-04
2022-12-31$0.00
10-K · filed 2023-03-23
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$0.00
10-K · filed 2022-03-30
2021-09-30$0.00
10-Q · filed 2021-11-17
2020-12-31$0.00
10-K · filed 2022-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Vaxart, Inc. (VXRT)United States$0.080B3.84
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41